文献速递腹部介入MR

半定量视觉评估肝肿瘤负荷可可靠预测经动脉化疗栓塞治疗的神经内分泌肿瘤肝转移患者生存

Semi-quantitative visual assessment of hepatic tumor burden can reliably predict survival in neuroendocrine liver metastases treated with transarterial chemoembolization.
PubMed 文献 · Eur Radiol · 2019-05-09

本研究评估MRI上半定量视觉评估肝肿瘤负荷(HTB)的准确性与可重复性,并探讨其预测经动脉化疗栓塞(TACE)治疗的神经内分泌肿瘤肝转移(NELM)患者总生存(OS)的预后价值。三位独立阅片者盲法回顾111例NELM患者的基线MRI,按欧洲神经内分泌肿瘤学会(ENETS)指南进行半定量HTB分类,以手动分割定量HTB为参考标准。结果显示半定量与定量HTB一致性加权kappa为0.82-0.96,阅片者内加权kappa为0.95,阅片者间加权kappa为0.84-0.91、ICC为0.98;半定量HTB为独立预后因素(多变量Cox回归p<0.001),Harrell C指数0.735,与定量HTB相当。结论认为半定量视觉评估准确、可重复,可可靠预测TACE治疗的NELM患者OS。

要点

  • 半定量视觉评估HTB与定量测量一致性高(加权kappa 0.82-0.96)。
  • 半定量HTB为TACE治疗的NELM患者OS的独立预后因素(p<0.001)。
  • 半定量与定量HTB的Harrell C指数均为0.735,预后价值相当。

核心结论

  • 基于MRI的半定量视觉评估HTB准确且可重复,可可靠预测TACE治疗的NELM患者OS。

研究设计与样本

  • 回顾性研究,纳入111例接受TACE治疗的NELM患者,三位独立阅片者盲法回顾基线MRI,按ENETS指南半定量分类HTB,以手动分割定量HTB为参考标准,采用加权kappa和ICC评估一致性,Kaplan-Meier曲线和Cox回归进行生存分析,计算Harrell C指数。

诊断标准与关键数值

  • 按定量HTB将患者分为≤10%(41例)、11-25%(29例)、26-50%(25例)和>50%(16例)四组,半定量评估依据ENETS指南分类;半定量与定量HTB的加权kappa为0.82-0.96,阅片者内加权kappa为0.95,阅片者间加权kappa为0.84-0.91、ICC为0.98;多变量Cox回归p<0.001,Harrell C指数半定量和定量HTB均为0.735。

临床应用与阅片要点

  • 阅片时可依据ENETS指南对NELM患者MRI上的HTB进行半定量视觉分类,该分类与定量测量高度一致且可重复,并可作为TACE治疗患者的独立预后因素。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the accuracy and reproducibility of semi-quantitative visual assessment of hepatic tumor burden (HTB) on MRI and to investigate its prognostic value in predicting overall survival (OS) in neuroendocrine liver metastases (NELMs) treated with transarterial chemoembolization (TACE).

METHODS: Three independent readers blinded to the quantitative HTB measurement reviewed baseline MRI in 111 NELM patients treated with TACE. Readers visually assessed and semi-quantitatively categorized HTB using the European Neuroendocrine Tumor Society (ENETS) guidelines. Quantitative HTB measured by manual segmentation was used as the reference standard. Agreements between quantitative and semi-quantitative measurement of HTB, as well as intra- and inter-reader reproducibility, were evaluated using weighted kappa coefficient and intraclass correlation coefficient (ICC). Survival analysis included the Kaplan-Meier curves and Cox regression. Harrell C-index was calculated to evaluate the prognostic value of semi-quantitative HTB for predicting OS.

RESULTS: According to quantitative HTB, 41, 29, 25, and 16 patients were categorized into ≤ 10%, 11-25%, 26-50%, and > 50% groups, respectively. Agreements between quantitative and semi-quantitative measurement of HTB by each reader (weighted kappa, 0.82-0.96), intra-reader agreement (weighted kappa, 0.95), and inter-reader agreements (weighted kappa, 0.84-0.91; ICC, 0.98) were at least substantial to almost perfect. Semi-quantitative HTB was an independent prognostic factor in NELMs treated with TACE (multivariate Cox regression, p < 0.001), with prognostic value comparable to that of quantitative HTB (Harrell C-index, 0.735 for both semi-quantitative and quantitative HTB in multivariate regression).

CONCLUSION: Semi-quantitative visual assessment of HTB using MRI is accurate and reproducible and could reliably predict OS in NELMs treated with TACE.

KEY POINTS: • Semi-quantitative visual assessment of HTB using MR imaging is considerably accurate, reproducible, and efficient. • Visually assessed semi-quantitative HTB serves as an independent predictor of OS in NELMs treated with TACE.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Luo Y, Ameli S, Pandey A, et al. Semi-quantitative visual assessment of hepatic tumor burden can reliably predict survival in neuroendocrine liver metastases treated with transarterial chemoembolization. Eur Radiol. 2019. PMID: 31073860. doi:10.1007/s00330-019-06246-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。